Acute physical stress induces the alteration of the serotonin 1A receptor density in the hippocampus

Synapse

Volumn 68, Issue 8, 2014, Pages 363-368

  Choi, Jae Yong ^a   Shin, Sora ^a   Lee, Minkyung ^a   Jeon, Tae Joo ^a   Seo, Youngbeom ^a   Kim, Chul Hoon ^a   Kim, Dong Goo ^a   Yi, Chi Hoon ^b   Lee, Kyochul ^b   Choi, Tae Hyun ^b   Kang, Jee Hae ^c   Ryu, Young Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Korea Institute of Radiation and Medical Science   (South Korea)

^c SWARTHMORE COLLEGE   (United States)

Author keywords

Acute stress; PET

Indexed keywords

SEROTONIN 1A RECEPTOR; FLUORINE; MEFWAY; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; FORCED SWIM TEST; HIPPOCAMPUS; IMAGE ANALYSIS; NONHUMAN; PET SCANNER; PHYSICAL STRESS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RAT; SEROTONINERGIC SYSTEM; ACUTE DISEASE; ANIMAL; CEREBELLUM; DIAGNOSTIC USE; DISEASE MODEL; METABOLISM; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; SCINTISCANNING; SPRAGUE DAWLEY RAT; SWIMMING; TIME;

ACUTE DISEASE; ANIMALS; CEREBELLUM; DEPRESSION; DISEASE MODELS, ANIMAL; FEMALE; FLUORINE RADIOISOTOPES; HIPPOCAMPUS; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; RADIOPHARMACEUTICALS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; STRESS, PHYSIOLOGICAL; SWIMMING; TIME FACTORS;

EID: 84902249398     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21748     Document Type: Article

References (38)

1. Adell A, Casanovas JM, Artigas F. 1997. Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology 36:735-741.
2. Bellido I, Gomez-Luque A, Garcia-Carrera P, Rius F, de la Cuesta FS. 2003. Female rats show an increased sensibility to the forced swim test depressive-like stimulus in the hippocampus and frontal cortex 5-HT1A receptors. Neurosci Lett 350:145-148.
3. Bowen DM, Najlerahim A, Procter AW, Francis PT, Murphy E. 1989. Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life. Proc Natl Acad Sci USA 86:9504-9508.
4. Carson RE, Channing MA, Blasberg RG, Dunn BB, Cohen RM, Rice KC, Herscovitch P. 1993. Comparison of bolus and infusion methods for receptor quantitation: Application to [18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab 13:24-42.
5. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. 2003. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389.
6. Choi JY, Kim CH, Jeon TJ, Kim BS, Yi CH, Woo KS, Seo YB, Han SJ, Kim KM, Yi DI, Lee M, Kim DG, Kim JY, Lee KC, Choi TH, An G, Ryu YH. 2012. Effective microPET imaging of brain 5-HT(1A) receptors in rats with [(18) F]MeFWAY by suppression of radioligand defluorination. Synapse 66:1015-1023.
7. Constantinescu CC, Sevrioukov E, Garcia A, Pan ML, Mukherjee J. 2013. Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice. Mol Imaging Biol 15:222-229.
8. Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C. 2007. Serotonin-1A receptor imaging in recurrent depression: Replication and literature review. Nucl Med Biol 34:865-877.
9. Mestikawy S, Riad M, Laporte AM, Verge D, Daval G, Gozlan H, Hamon M. 1990. Production of specific anti-rat 5-HT1A receptor antibodies in rabbits injected with a synthetic peptide. Neurosci Lett 118:189-192.
10. Fink G. 2010. Stress science: neuroendocrinology. San Diego, CA: Academic Press.
11. Grasby PM, Bench C. 1997. Neuroimaging of mood disorders. Curr Opin Psychiatry 10:73-78.
12. Hirvonen J, Karlsson H, Kajander J, Lepola A, Markkula J, Rasi-Hakala H, Nagren K, Salminen JK, Hietala J. 2008. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: An in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int J Neuropsychopharmacol 11:465-476.
13. Huang EJ, Reichardt LF. 2001. Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci 24:677-736.
14. Innis RB, Cunningham VJ, Delforge J, Fujita M, Giedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Lida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE. 2007. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533-1539.
15. Ito H, Hietala J, Blomqvist G, Halldin C, Farde L. 1998. Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding. J Cereb Blood Flow Metab 18:941-950.
16. Jang DP, Lee SH, Lee SY, Park CW, Cho ZH, Kim YB. 2009. Neural responses of rats in the forced swimming test: [F-18]FDG micro PET study. Behav Brain Res 203:43-47.
17. Kendler KS, Karkowski LM, Prescott CA. 1999. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 156:837-841.
18. Kirby LG, Allen AR, Lucki I. 1995. Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res 682:189-196.
19. Lanfumey L, Mongeau R, Cohen-Salmon C, Hamon M. 2008. Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev 32:1174-1184.
20. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, Sequeira A, Kushwaha N, Morris SJ, Basak A, Ou XM, Albert PR. 2003. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23:8788-8799.
21. Lopez JF, Chalmers DT, Little KY, Watson SJ. 1998. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: Implications for the neurobiology of depression. Biol Psychiatry 43:547-573.
22. Maniam J, Morris MJ. 2010. Voluntary exercise and palatable high-fat diet both improve behavioural profile and stress responses in male rats exposed to early life stress: Role of hippocampus. Psychoneuroendocrinology 35:1553-1564.
23. Monteleone P, Serritella C, Martiadis V, Maj M. 2008. Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. Bipolar Disord 10:95-100.
24. Moses-Kolko EL, Wisner KL, Price JC, Berga SL, Drevets WC, Hanusa BH, Loucks TL, Meltzer CC. 2008. Serotonin 1A receptor reductions in postpartum depression: A positron emission tomography study. Fertil Steril 89:685-692.
25. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. 2002. Neurobiology of depression. Neuron 34:13-25.
26. Nugent AC, Bain EE, Carlson PJ, Neumeister A, Bonne O, Carson RE, Eckelman W, Herscovitch P, Zarate CA, Jr., Charney DS, Drevets WC. 2013. Reduced post-synaptic serotonin type 1A receptor binding in bipolar depression. Eur Neuropsychopharmacol 23:822-829.
27. Pazos A, Palacios JM. 1985. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346:205-230.
28. Porsolt RD, Le Pichon M, Jalfre M. 1977. Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730-732.
29. Pruessner JC, Dedovic K, Khalili-Mahani N, Engert V, Pruessner M, Buss C, Renwick R, Dagher A, Meaney MJ, Lupien S. 2008. Deactivation of the limbic system during acute psychosocial stress: Evidence from positron emission tomography and functional magnetic resonance imaging studies. Biol Psychiatry 63:234-240.
30. Rabiner EA, Bhagwagar Z, Gunn RN, Sargent PA, Bench CJ, Cowen PJ, Grasby PM. 2001. Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low. Am J Psychiatry 158:2080-2082.
31. Saigal N, Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. 2006. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate. J Nucl Med 47:1697-1706.
32. Smith MA, Makino S, Kvetnansky R, Post RM. 1995. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15(3 Pt 1):1768-1777.
33. Stockmeier CA, Dilley GE, Shapiro LA, Overholser JC, Thompson PA, Meltzer HY. 1997. Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology 16:162-173.
34. 1A receptor binding in the ventral hippocampus. Brain Res 1090:29-34.
35. Wooten D, Hillmer A, Murali D, Barnhart T, Schneider ML, Mukherjee J, Christian BT. 2011a. An in vivo comparison of cis- and trans-[18F]mefway in the nonhuman primate. Nucl Med Biol 38:925-932.
36. Wooten DW, Moraino JD, Hillmer AT, Engle JW, Dejesus OJ, Murali D, Barnhart TE, Nickles RJ, Davidson RJ, Schneider ML, Mukherjee J, Christian BT. 2011b. In vivo kinetics of [F-18]MEFWAY: A comparison with [C-11]WAY100635 and [F-18]MPPF in the nonhuman primate. Synapse 65:592-600.
37. Wooten DW, Hillmer AT, Moirano JM, Ahlers EO, Slesarev M, Barnhart TE, Mukherjee J, Schneider ML, Christian BT. 2012. Measurement of 5-HT(1A) receptor density and in-vivo binding parameters of [(18)F]mefway in the nonhuman primate. J Cerebral Blood Flow Metab 32:1546-1558.
38. Zardooz H, Rostamkhani F, Zaringhalam J, Faraji Shahrivar F. 2010. Plasma corticosterone, insulin and glucose changes induced by brief exposure to isoflurane, diethyl ether and CO2 in male rats. Physiol Res 59:973-978.